Implementing Levodopa-Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners

about

Implementing Levodopa-Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners

Item

http://www.wikidata.org/entity/Q58571815

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2018

@uk

name

Implementing Levodopa-Carbidop ...... Insights from US Practitioners

@en

Implementing Levodopa-Carbidop ...... Insights from US Practitioners

@nl

type

Item

label

Implementing Levodopa-Carbidop ...... Insights from US Practitioners

@en

Implementing Levodopa-Carbidop ...... Insights from US Practitioners

@nl

prefLabel

Implementing Levodopa-Carbidop ...... Insights from US Practitioners

@en

Implementing Levodopa-Carbidop ...... Insights from US Practitioners

@nl

P1476

Implementing Levodopa-Carbidop ...... Insights from US Practitioners

@en

P2093

Arvydas Vanagunas

http://www.w3.org/2001/XMLSchema#string

Bahri Bilir

http://www.w3.org/2001/XMLSchema#string

Cindy Zadikoff

http://www.w3.org/2001/XMLSchema#string

Jason Aldred

http://www.w3.org/2001/XMLSchema#string

Kevin Klos

http://www.w3.org/2001/XMLSchema#string

Michelle Burack

http://www.w3.org/2001/XMLSchema#string

P2860

Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program

Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease.

Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management.

Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results

Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review

Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trials.

Motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational study.

Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients.

P304

383-393

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDC3.12630

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David G. Standaert

Hubert H Fernandez

P577

2018-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30363427

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

levodopa

P932

6174493

http://www.w3.org/2001/XMLSchema#string